Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousBone Marrow CellsBone MarrowStem Cell TransplantationGraft vs Host DiseaseHematopoietic Stem CellsTransplantation ConditioningHematopoietic Stem Cell MobilizationStem CellsGranulocyte Colony-Stimulating FactorHematologic NeoplasmsGraft SurvivalAntigens, CD34Whole-Body IrradiationTransplantation ChimeraBusulfanLeukapheresisCombined Modality TherapyCyclophosphamideBone and BonesMelphalanTreatment OutcomeTissue DonorsHematopoiesisLeukemiaRecurrenceAnemia, AplasticBlood Component RemovalMultiple MyelomaHistocompatibilityHistocompatibility TestingCell DifferentiationRemission InductionAntineoplastic Combined Chemotherapy ProtocolsTransplantation, IsogeneicTime FactorsLymphoma, Non-HodgkinMice, Inbred C57BLCord Blood Stem Cell TransplantationMyeloablative AgonistsBone Marrow DiseasesMesenchymal Stem Cell TransplantationLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow PurgingImmunosuppressive AgentsRadiation ChimeraColony-Forming Units AssayEtoposideGraft vs Leukemia EffectCells, CulturedRetrospective StudiesFlow CytometryLymphocyte DepletionAntineoplastic Agents, AlkylatingMyelodysplastic SyndromesSurvival AnalysisPrecursor Cell Lymphoblastic Leukemia-LymphomaDisease-Free SurvivalAdult Stem CellsLiver TransplantationInfectionSurvival RateT-LymphocytesCell SeparationCytarabineBlood CellsThiotepaMesenchymal Stromal CellsImmunosuppressionCytomegalovirus InfectionsSalvage TherapyGraft vs Tumor EffectCarmustineLeukocyte TransfusionHematologic DiseasesBone Marrow ExaminationAcute DiseaseBone RemodelingCyclosporineHodgkin DiseaseHLA AntigensVidarabineCell LineageLymphomaPOEMS SyndromeFatal OutcomeAntigens, CDTransplantation ImmunologyVincristineImmunophenotypingFollow-Up StudiesLeukemia, MyeloidPlatelet CountBone Marrow NeoplasmsLymphocyte Transfusion